Apathy: Neurobiology, Assessment and Treatment
Clinical Psychopharmacology and Neuroscience
; : 181-189, 2021.
Article
in En
| WPRIM
| ID: wpr-897922
Responsible library:
WPRO
ABSTRACT
Apathy is a highly prevalent, disabling and treatment resistant syndrome. It is defined as a quantitative reduction of goaldirected activity in comparison to the patient’s previous level of in multiple dimensions including behavior/cognition, emotion and social interaction. It has been described in major depressive disorder, Alzheimer’s disease, frontotemporal dementia, Parkinson’s Disease, cerebrovascular disease, and vascular dementia, among others. This review will address the neuropsychology and associated neurobiological underpinnings of apathy in the above conditions, identify specific methods to assess apathy clinically, and review the literature on managing apathy across these various disorders.
Full text:
1
Index:
WPRIM
Language:
En
Journal:
Clinical Psychopharmacology and Neuroscience
Year:
2021
Type:
Article